Last reviewed · How we verify

Regional Block 2: QL1 — Competitive Intelligence Brief

Regional Block 2: QL1 (Regional Block 2: QL1) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Anesthesiology.

phase 3 Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Regional Block 2: QL1 (Regional Block 2: QL1) — Jennifer Holder-Murray. This drug is used to block nerve signals in a specific region of the body.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Regional Block 2: QL1 TARGET Regional Block 2: QL1 Jennifer Holder-Murray phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Regional Block 2: QL1 — Competitive Intelligence Brief. https://druglandscape.com/ci/regional-block-2-ql1. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing